Dudley & Shanley, Inc. Bristol Myers Squibb CO Transaction History

Dudley & Shanley, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$72.62 - $79.98 $375,808 - $413,896	-5,175 Reduced 2.02%	251,196 $19.3 Million
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $9.84 Million - $11.8 Million	160,130 Added 166.38%	256,371 $18.7 Million
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $25.6 Million - $29.8 Million	-476,769 Reduced 83.2%	96,241 $6 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $1.3 Million - $1.52 Million	-21,990 Reduced 3.7%	573,010 $33.9 Million
Q2 2021 Jul 12, 2021	BUY	$61.91 - $67.42 $89,769 - $97,759	1,450 Added 0.24%	595,000 $39.8 Million
Q1 2021 Apr 21, 2021	SELL	$59.34 - $66.74 $376,215 - $423,131	-6,340 Reduced 1.06%	593,550 $37.5 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $7.69 Million - $8.72 Million	133,200 Added 28.54%	599,890 $37.2 Million
Q3 2020 Nov 03, 2020	BUY	$57.43 - $63.64 $4.77 Million - $5.29 Million	83,100 Added 21.66%	466,690 $28.1 Million
Q2 2020 Jul 21, 2020	SELL	$54.82 - $64.09 $5.28 Million - $6.18 Million	-96,400 Reduced 20.08%	383,590 $22.6 Million
Q1 2020 Apr 20, 2020	BUY	$46.4 - $67.43 $7.29 Million - $10.6 Million	157,115 Added 48.66%	479,990 $26.8 Million
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $15.9 Million - $20.7 Million	322,875 New	322,875 $20.7 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dudley & Shanley, Inc., based on Form 13F filings with the SEC.

Stay updated on Dudley & Shanley, Inc. with notifications on news.